Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine/Cisplatin vs Gemcitabine in Biliary Tract Cancer
NCT00380588Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Primary completion
- Oct 2008
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, Cisplatin micelle injection (HA132) in biliary tract cancer (BTC), sponsored by Eli Lilly and Company. Started Sep 2006; status: completed.
02
Drugs
gemcitabineCisplatin micelle injection (HA132)
03
Conditions
biliary tract cancer (BTC)
Beyond the preview
Go deeper on NCT00380588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00380588.